The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
